Health News Round up: Dutch to prosecute doctor for euthanasia on woman with dementia
U.S. regulators snip red tape for medical devices to curb opioid crisis
Laura Perryman expected her medical company, Stimwave Technologies Inc, would have to wait several years for its painkilling device to win U.S. approval as a treatment for chronic migraines. She now thinks it could be done in months, thanks to a new initiative by the U.S. Food and Drug Administration to use medical device-based treatments, diagnostic tests and mobile medical apps to address the country's opioid crisis.
China's Sichuan province bans live hog, hog product imports to prevent African swine fever
China's Sichuan province has banned the import of all live hogs and hog products from other regions to prevent African swine fever, the provincial government said in a notice posted on its website on Friday. The ban was effective from Nov. 8 and comes after several provinces bordering Sichuan reported outbreaks of the highly contagious disease.
U.S. concerned about Ebola outbreak in Congo conflict zone: official
The United States is worried about the outbreak of Ebola in conflict-hit eastern Congo where there are 312 confirmed and probable cases and 191 deaths, a USAID official said on Thursday. "We are absolutely concerned about the ongoing outbreak in the Democratic Republic of Congo," the senior USAID official, who is working with response teams, told Reuters. "It is not comparable at this point to the outbreak that occurred in West Africa in 2014," which spread to nine countries and involved more than 28,000 cases, she said.
Novartis division Sandoz recalls one lot of blood pressure drug
Novartis said on Thursday its Sandoz division was recalling one lot of losartan tablets after finding traces of a probable carcinogen in the blood pressure drug. The drug is made by China's Zhejiang Huahai Pharmaceutical Co Ltd. Last month, the European Medicines Agency placed the firm under high supervision after a probable carcinogen was found in its blood pressure drug valsartan.
Dutch to prosecute doctor for euthanasia on woman with dementia
Dutch prosecutors launched a criminal case on Friday against a doctor for performing euthanasia on an Alzheimer's sufferer without adequately confirming she wanted to die, the first case of its kind since mercy killing was legalized in 2002. The 74-year-old woman, who had been diagnosed with Alzheimer's disease four years before her death, had a certified living will stating her wish for euthanasia if her condition were to worsen significantly.
FDA to announce ban on flavored e-cigarettes as soon as next week - Washington Post
The U.S. Food and Drug Administration is expected to announce a ban on the sale of flavored e-cigarettes in convenience stores and gas stations across the country as soon as next week, the Washington Post reported on Thursday. The FDA will also impose rules such as age-verification requirements for online sales, the paper reported https://wapo.st/2Dvb7x9, citing senior agency officials.
U.S. to restrict e-cigarette flavors to fight teenage vaping 'epidemic'
The U.S. Food and Drug Administration next week will issue a ban on the sale of fruit and candy flavored electronic cigarettes in convenience stores and gas stations, an agency official said, in a move to counter a surge in teenage use of e-cigarettes. The ban means only tobacco, mint and menthol flavors can be sold at these outlets, the agency official said, potentially dealing a major blow to Juul Labs Inc, the San Francisco-based market leader in vape devices.
Endo targets 2020 for launch of cellulite treatment
Endo International Plc said on Thursday it expects to launch its treatment for cellulite in the second half of 2020, a day after the company announced results from two late-stage trials testing the drug. The generic drugmaker, which beat third-quarter revenue and profit estimates, has pushed into other segments of its business, such as medical aesthetics, to cushion the impact of large retail pharmacies gaining more negotiating power for generics pricing.
Mylan and Theravance's COPD treatment gets FDA approval
Theravance Biopharma Inc and partner Mylan NV on Friday won U.S. regulatory approval for their treatment for a chronic lung condition that causes breathing-related problems. The treatment, Yupelri https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210598s000lbl.pdf, is a once-daily inhalable solution to be used by patients of chronic obstructive pulmonary disease (COPD), a lung disease characterized by wheezing or chronic cough.
Coherus prices biosimilar to Amgen's Neulasta at 33 percent discount
Coherus BioSciences Inc said on Thursday it would price its biosimilar to Amgen Inc's infection-fighting treatment, Neulasta, at a 33 percent discount. The list price of $4,175 per unit set by Coherus is the same as Mylan NV's biosimilar Fulphila that was approved earlier this year.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)